SCHEMBL19904518

SCHEMBL19904518

O=C(NC(Cc1ccc2c(c1)OCCO2)CN1CCC1)C1CCN(c2ccc3cc(F)ccc3c2)C1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.43
LMNA P02545 1/20 0.41
PKM P14618 1/20 0.41
SSTR3 P32745 4/20 0.40
KMT2A Q03164 2/20 0.39
ACACB O00763 8/20 0.38
DRD2 P14416 1/20 0.38
DRD4 P21917 1/20 0.38
DRD3 P35462 1/20 0.38
SSTR1 P30872 1/20 0.38
USP2 O75604 1/20 0.37
ALDH1A1 P00352 1/20 0.37
HPGD P15428 1/20 0.37
TSHR P16473 1/20 0.37
MAPK1 P28482 1/20 0.37
HTT P42858 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
HSD17B10 Q99714 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
CCR3 P51677 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19904409 1.00 KDM4E (0.43) KDM4ELMNAPKMSSTR3KMT2A
SCHEMBL19904458 0.98 KDM4E (0.43) KDM4ELMNAPKMSSTR3KMT2A
SCHEMBL19904326 0.98 KDM4E (0.43) KDM4ELMNAPKMSSTR3KMT2A
SCHEMBL19904431 0.91 SSTR3 (0.45) KDM4ELMNAPKMSSTR3KMT2A
SCHEMBL19904527 0.91 MCHR1 (0.41) LMNAKMT2AACACBUSP2ALDH1A1
SCHEMBL19904325 0.91 MCHR1 (0.41) LMNAKMT2AACACBUSP2ALDH1A1
SCHEMBL19904671 0.90 SSTR3 (0.45) KDM4ELMNAPKMSSTR3KMT2A
SCHEMBL19904535 0.90 KDM4E (0.37) KDM4ELMNAPKMSSTR3ACACB
SCHEMBL19904324 0.90 KDM4E (0.37) KDM4ELMNAPKMSSTR3ACACB
SCHEMBL19904498 0.89 KDM4E (0.37) KDM4ELMNAPKMSSTR3ACACB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3063141-B1 N-(1-HYDROXY-3-(PYRROLIDINYL)PROPAN-2-YL)PYRROLIDINE-3-CARBOXAMIDE DERIVATIVES AS GLUCOSYLCERAMIDE SYNTHASE INHIBITORS BIOMARIN PHARM INC (US) 2018-02-28 EP disclosed